![]() | |
| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| ECHA InfoCard | 100.013.215 |
| Chemical and physical data | |
| Formula | C11H15BrN2O3 |
| Molar mass | 303.156 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Butallylonal is a barbiturate derivative invented in the 1920s.[1] It has sedative properties, and was used primarily as an anaesthetic in veterinary medicine.[2] Butallylonal is considered similar in effects to pentobarbital but is longer in action, being considered an intermediate-acting barbiturate rather than short-acting.
References
- ↑ US 1739662
- ↑ Mittmann U, Schmidt HD, Schmier J, Wirth RH (1976). "Hemorrhagic shock with fixed hypotension and with spontaneous recovery of blood pressure. A comparison of two shock models". Basic Research in Cardiology. 71 (1): 47–59. doi:10.1007/BF01907782. PMID 1259685. S2CID 5567045.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
